Latest Breaking News On - Eneuro porteur aktie - Page 1 : comparemela.com

11.09.2023 - Regulatory News: GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing treatments for neurodegenerative and autoimmune diseases, such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and the severe . Seite 1

France generalUnited statesPsychiatry department of the crSchizophrenia international research societyRobert yolken johns hopkins universityPsychiatry departmentRobert yolkenJohns hopkins universityGeneuro porteur chartEneuro porteur kursEneuro porteur aktie